| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
|
Pérez-Ruiz, Elisabeth
|
|
|
53 |
C |
p.
|
article
|
| 2 |
Corrigendum to “Dopamine and serotonin regulate tumor behavior by affecting angiogenesis” [Drug Resist. Updat. 17 (2014) 96–104]
|
Peters, Marloes A.M.
|
|
|
53 |
C |
p.
|
article
|
| 3 |
COVID-19 update: The race to therapeutic development
|
Twomey, Julianne D.
|
|
|
53 |
C |
p.
|
article
|
| 4 |
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses
|
Artese, Anna
|
|
|
53 |
C |
p.
|
article
|
| 5 |
Editorial Board
|
|
|
|
53 |
C |
p.
|
article
|
| 6 |
Ex vivo cultures and drug testing of primary acute myeloid leukemia samples: Current techniques and implications for experimental design and outcome
|
Cucchi, D.G.J.
|
|
|
53 |
C |
p.
|
article
|
| 7 |
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
|
Drożdżal, Sylwester
|
|
|
53 |
C |
p.
|
article
|
| 8 |
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
|
Li, Bowen
|
|
|
53 |
C |
p.
|
article
|
| 9 |
The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology
|
Wiesel-Motiuk, Naama
|
|
|
53 |
C |
p.
|
article
|
| 10 |
The role of alternative splicing in cancer: From oncogenesis to drug resistance
|
Sciarrillo, Rocco
|
|
|
53 |
C |
p.
|
article
|
| 11 |
Thirty years of VRE in Germany – “expect the unexpected”: The view from the National Reference Centre for Staphylococci and Enterococci
|
Werner, Guido
|
|
|
53 |
C |
p.
|
article
|
| 12 |
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
|
Erin, Nuray
|
|
|
53 |
C |
p.
|
article
|
Journal description